
Here's Why Adient (ADNT) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Adient (NYSE: ADNT - Get Free Report) has been given a consensus recommendation of "Hold" by the twelve research firms that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating on the company. The average twelve-month

Adient (ADNT) reported earnings 30 days ago. What's next for the stock?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Counterpoint Mutual Funds LLC lowered its holdings in Adient (NYSE: ADNT) by 51.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,755 shares of the company's stock after selling 22,424 shares during the period. Counterpoint Mutual Funds LLC's holdings

PLYMOUTH, Mich., Feb. 23, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its latest breakthrough innovation, Sculpted Soft Trim.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Adient (NYSE: ADNT - Get Free Report) and China Yuchai International (NYSE: CYD - Get Free Report) are both auto/tires/trucks companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations. Volatility and Risk Adient has a beta of

Adient Q1 EPS beats estimates as revenues rise 4.3% year over year, with all three segments topping sales forecasts and fiscal 2026 guidance raised.

Adient plc (ADNT) Q1 2026 Earnings Call Transcript

Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Adient (ADNT) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.27 per share a year ago.

PLYMOUTH, Mich., Feb. 4, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its first quarter 2026 financial results.

Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Adient (NYSE: ADNT - Get Free Report) is expected to be announcing its Q1 2026 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $3.4488 billion for the quarter. Individuals are encouraged to explore the company's upcoming Q1 2026 earning overview page

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PLYMOUTH, Mich., Jan. 22, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced its latest breakthrough innovation, ModuTec.

Shares of Adient (NYSE: ADNT - Get Free Report) have been assigned an average recommendation of "Hold" from the eleven brokerages that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and three have given a buy recommendation to the

Five low price-to-book stocks stand out for 2026, as undervalued valuations and solid growth outlooks put them on investors' radar.